CAR T drives acute myeloid leukemia into submission in pre-clinical studies
A chimeric antigen receptor (CAR) T-cell construct designed to overcome difficulties with prior attempts showed good efficacy against AML in mouse models.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Treats:
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Mass General is the #1 Research Hospital in America and recognized in 14 specialties assessed by U.S. News & World Report.
A chimeric antigen receptor (CAR) T-cell construct designed to overcome difficulties with prior attempts showed good efficacy against AML in mouse models.